Phase II and Phase III attrition rates 2011–2012. Arrowsmith, J. & Miller, P. Nature Reviews Drug Discovery, 12(8):569–569, August, 2013.
Paper doi bibtex @article{arrowsmith_phase_2013-1,
title = {Phase {II} and {Phase} {III} attrition rates 2011–2012},
volume = {12},
issn = {1474-1776, 1474-1784},
url = {http://www.nature.com/articles/nrd4090},
doi = {10.1038/nrd4090},
language = {en},
number = {8},
urldate = {2019-05-02},
journal = {Nature Reviews Drug Discovery},
author = {Arrowsmith, John and Miller, Philip},
month = aug,
year = {2013},
pages = {569--569},
file = {Arrowsmith and Miller - 2013 - Phase II and Phase III attrition rates 2011–2012.pdf:/Users/neil.hawkins/Zotero/storage/5SVHGHEC/Arrowsmith and Miller - 2013 - Phase II and Phase III attrition rates 2011–2012.pdf:application/pdf},
}
Downloads: 0
{"_id":"u2N7vY5RRjAAo47ik","bibbaseid":"arrowsmith-miller-phaseiiandphaseiiiattritionrates20112012-2013","author_short":["Arrowsmith, J.","Miller, P."],"bibdata":{"bibtype":"article","type":"article","title":"Phase II and Phase III attrition rates 2011–2012","volume":"12","issn":"1474-1776, 1474-1784","url":"http://www.nature.com/articles/nrd4090","doi":"10.1038/nrd4090","language":"en","number":"8","urldate":"2019-05-02","journal":"Nature Reviews Drug Discovery","author":[{"propositions":[],"lastnames":["Arrowsmith"],"firstnames":["John"],"suffixes":[]},{"propositions":[],"lastnames":["Miller"],"firstnames":["Philip"],"suffixes":[]}],"month":"August","year":"2013","pages":"569–569","file":"Arrowsmith and Miller - 2013 - Phase II and Phase III attrition rates 2011–2012.pdf:/Users/neil.hawkins/Zotero/storage/5SVHGHEC/Arrowsmith and Miller - 2013 - Phase II and Phase III attrition rates 2011–2012.pdf:application/pdf","bibtex":"@article{arrowsmith_phase_2013-1,\n\ttitle = {Phase {II} and {Phase} {III} attrition rates 2011–2012},\n\tvolume = {12},\n\tissn = {1474-1776, 1474-1784},\n\turl = {http://www.nature.com/articles/nrd4090},\n\tdoi = {10.1038/nrd4090},\n\tlanguage = {en},\n\tnumber = {8},\n\turldate = {2019-05-02},\n\tjournal = {Nature Reviews Drug Discovery},\n\tauthor = {Arrowsmith, John and Miller, Philip},\n\tmonth = aug,\n\tyear = {2013},\n\tpages = {569--569},\n\tfile = {Arrowsmith and Miller - 2013 - Phase II and Phase III attrition rates 2011–2012.pdf:/Users/neil.hawkins/Zotero/storage/5SVHGHEC/Arrowsmith and Miller - 2013 - Phase II and Phase III attrition rates 2011–2012.pdf:application/pdf},\n}\n\n","author_short":["Arrowsmith, J.","Miller, P."],"bibbaseid":"arrowsmith-miller-phaseiiandphaseiiiattritionrates20112012-2013","role":"author","urls":{"Paper":"http://www.nature.com/articles/nrd4090"},"metadata":{"authorlinks":{}}},"bibtype":"article","biburl":"https://bibbase.org/f/FfNE7kWA6pCvwcJZF/myPubs.bib","dataSources":["ZaHtWavQhcwZqKLNF","iRRNaRs6FkffgErta","v8uQmZsBpiqycmskv"],"keywords":[],"search_terms":["phase","phase","iii","attrition","rates","2011","2012","arrowsmith","miller"],"title":"Phase II and Phase III attrition rates 2011–2012","year":2013}